A pharmaceutically acceptable salt of the compound of formula I or a solvate of said salt in which the compound of formula I is as the (R)-enantiomer, the (S)-enantiomer or the racemate ##STR13## with the proviso that (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4 -morpholinobenzamide hydrogen (2S,3S)-tartrate, (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4 -morpholinobenzamide hydrogen (2R,3R)-tartrate, (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4 -morpholinobenzamide benzenesulfonate, (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4 -morpholinobenzamide hydrogen 1,2-ethanedisulfonate, (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4 -morpholinobenzamide hydrogen maleate, (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4 -morpholinobenzamide hydrogen sulfate, (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4 -morpholinobenzamide D-gluconate, (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4 -morpholinobenzamide hydrogen succinate, (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4 -morpholinobenzamide methanesulfonate, (R)-N-[5-mnethyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]- 4-morpholinobenzamide hydrogen (S)-maleate, (R)-N-[.sup.5 -methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpho linobenzamide dihydrogen citrate and (R)-N-[.sup.5 -methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpho linobenzamide hydrochloride are excluded.
›2.↳ 1A pharmaceutically acceptable salt according to claim 1 in which the compound of formula I is an (R)-enantiomer or a solvate of said salt.d2
A pharmaceutically acceptable salt according to claim 1 in which the compound of formula I is an (R)-enantiomer or a solvate of said salt.
›3.↳ 1A salt or solvate according to claim 1 which is (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]- 4-morpholinobenzamide L-lac…d2
A salt or solvate according to claim 1 which is (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]- 4-morpholinobenzamide L-lactate or a solvate thereof.
›4.↳ 1A salt or solvate according to claim 1 which is (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]- 4-morpholinobenzarnide L-as…d2
A salt or solvate according to claim 1 which is (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]- 4-morpholinobenzarnide L-ascorbate or a solvate thereof.
›5.↳ 1A salt or solvate according to claim 1 which is (R)-N-[5-methyl-8-(4-methylpiperazin-1yl)-1,2,3,4-tetrahydro-2-naphthyl]-4 -morpholinobenzamide salicy…d2
A salt or solvate according to claim 1 which is (R)-N-[5-methyl-8-(4-methylpiperazin-1yl)-1,2,3,4-tetrahydro-2-naphthyl]-4 -morpholinobenzamide salicylate or a solvate thereof.
›6.↳ 1A salt or solvate according to claim 1 which is (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]- 4-morpholinobenzamide glyco…d2
A salt or solvate according to claim 1 which is (R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]- 4-morpholinobenzamide glycolate or a solvate thereof.
›7.↳ 1A salt or solvate according to claim 1 which is R)-N-[5-Methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4 -morpholinobenzamide dihydr…d2
A salt or solvate according to claim 1 which is R)-N-[5-Methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4 -morpholinobenzamide dihydrobromide or a solvate thereof.
›8.↳ 1A salt or solvate according to claim 1 which is R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4 -morpholinobenzamide monohy…d2
A salt or solvate according to claim 1 which is R)-N-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4 -morpholinobenzamide monohydrobromide or a solvate thereof.
›9.↳ 1A salt or solvate according to claim 1 which is R)-N-[5-Methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4 -morpholinobenzamide dihydr…d2
A salt or solvate according to claim 1 which is R)-N-[5-Methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4 -morpholinobenzamide dihydrochloride or a solvate thereof.
›20.↳ 1A process for the preparation of the salt of the compound of formula I or the solvate of said salt according to claim 1, comprising acylation of a com…d2
A process for the preparation of the salt of the compound of formula I or the solvate of said salt according to claim 1, comprising acylation of a compound of formula XII, ##STR14## with activated 4-morpholinobenzoic acid and reaction of the base with an organic or inorganic acid to form the salt with or without a solvate.
